Press release
Decentralized clinical trials Market Outlook 2025-2033: $8.68B to $29.9B Growth Driven by Telemedicine & Wearables
Decentralized clinical trials Market
Market Overview
Decentralized clinical trials (DCTs) leverage digital technologies such as telemedicine, wearable sensors, and electronic data capture (EDC) systems to conduct clinical research remotely, reducing the need for in-person site visits. These trials enhance patient accessibility, improve retention, and accelerate study timelines, addressing limitations of traditional site-centric models. The market is driven by technological advancements, regulatory support, and rising demand for patient-centric research, particularly in oncology and chronic disease management. However, challenges like data privacy and regulatory standardization persist.
📌 Access valuable insights with our sample report - (Please enter your Corporate Email ID to get priority access):- https://www.datamintelligence.com/download-sample/decentralized-clinical-trials-market?rk
Market Opportunities
Key opportunities include expanding DCT adoption in emerging markets, integrating AI and machine learning for data analytics, and developing hybrid trial models that combine remote and in-person components. Growing investment in digital health platforms and supportive regulatory frameworks, such as the FDA's 2024 guidance, further enhance market potential.
Key Trends
Increased use of wearable devices, telemedicine, and eConsent for real-time data collection.
Growing adoption of hybrid trial designs for flexibility and cost-effectiveness.
Rising focus on patient-centric models to improve engagement and diversity in trials.
Recent Developments
November 2024: Medable Inc. launched Medable AI, enabling one-day study startups by automating trial setup processes for sponsors and CROs.
May 2025: Ohio State University's Phase II pancreatic cancer study adopted a fully decentralized approach using telemedicine for patient follow-ups.
August 2024: Walgreens and BARDA partnered to advance DCT capabilities under the D-COHRe program, supporting FDA-regulated product development.
October 2024: Adaptive Research joined PhotoPharmics' LIGHT-PD trial for Parkinson's, leveraging DCT technology for remote monitoring.
February 2023: Nova Scotia Health Innovation Hub selected Medable's DCT platform for oncology trials, enhancing rural patient access via telemedicine.
Market Dynamics: Drivers
Technological Advancements
Advancements in digital health technologies, such as AI-driven platforms, wearable sensors, and telemedicine, are key drivers. For instance, Medable's AI platform (November 2024) enables one-day study startups by automating trial setup processes, reducing time to first patient in (FPI). Wearables like BioTelemetry's ECG patches and continuous glucose monitors enable real-time monitoring, minimizing clinic visits and improving compliance. During the COVID-19 pandemic, Pfizer's vaccine booster study utilized telemedicine and direct-to-patient drug shipments, demonstrating DCTs' ability to accelerate recruitment and enhance efficiency.
Market Dynamics: Restraints
Data Privacy and Security Concerns
Data privacy is a significant challenge, as DCTs rely on real-time data from wearables, smartphones, and cloud-based EDC systems. In 2024, healthcare data breaches exposed 276.7 million records globally, with 1.75 million affected in March 2025 alone (HIPAA Journal, 2024). These breaches highlight vulnerabilities in decentralized data streams, potentially deterring adoption and increasing costs for robust cybersecurity measures.
📌 Speak to Our Senior Analyst and Get Customization in the report as per your requirements:
https://www.datamintelligence.com/customize/decentralized-clinical-trials-market
Market Segment Analysis
By Study Type
Interventional trials dominate with a 63.73% share in 2024 due to their compatibility with remote monitoring and structured endpoints. Observational and expanded access trials are also growing, driven by real-world evidence (RWE) needs.
By Component
Cloud-based platforms held a 58.23% share in 2024, with hybrid/app-centric solutions projected to grow at a 17.01% CAGR through 2030. Technologies like eConsent and telemedicine are critical for scalability.
By Therapeutic Area: Oncology Leads
The oncology segment held a 23.15% share in 2024, driven by the global rise in cancer cases (35 million projected by 2050, WHO). DCTs enable remote monitoring for long-term oncology trials, as seen in the Ohio State University's Phase II pancreatic cancer study (May 2025), which used telemedicine for patient follow-ups.
By End-User
Pharmaceutical and biotech sponsors led with a 57.54% share in 2024, while medical device manufacturers are the fastest-growing segment at a 17.34% CAGR through 2030, driven by wearable technology advancements.
By Region
North America dominates, while Asia-Pacific is the fastest-growing region due to cost advantages and diverse populations.
Geographical Share
North America Holds Significant Share
North America accounted for a 43.02% market share in 2024, driven by advanced healthcare infrastructure, regulatory support, and major players like Medable and IQVIA. The U.S. leads with innovations like Medable AI (November 2024) and Pfizer's DCT modules for eConsent and remote monitoring. The region's 890 DCTs in 2023-2024 reflect its leadership in trial innovation.
Asia-Pacific Grows Rapidly
Asia-Pacific held a 21.07% share in 2024, with a 15.67% CAGR through 2030. The region's 4.83 billion diverse population and 30-40% lower trial costs (Clinical Leader) make it attractive for DCTs. Countries like China and India are investing in digital health infrastructure, boosting adoption.
📌 Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=decentralized-clinical-trials-market
Major Players
Key companies in the DCT market include:
ICON plc
Parexel International Corporation
Laboratory Corporation of America Holdings
Medpace, Inc.
Science 37
THREAD, Inc.
Curebase
Castor
IQVIA Inc.
Medable Inc.
Emerging Players
Veeva Systems Inc.
PRAXIS
Advarra
The Emmes Company, LLC
Syneos Health
📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription
☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring
☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Decentralized clinical trials Market Outlook 2025-2033: $8.68B to $29.9B Growth Driven by Telemedicine & Wearables here
News-ID: 4172025 • Views: …
More Releases from DataM Intelligence 4market Research LLP
United States Feed Testing Market Booms on 6.50% CAGR - North America Dominates …
According to DataM Intelligence, the global feed testing market size was valued at US$3.50 billion in 2024 and is forecasted to reach US$5.70 billion by 2031, growing at a CAGR of 6.50% during the forecast period (2024-2031). This steady growth is propelled by stringent regulatory standards for animal feed safety, rising demand for high-quality meat and dairy products, increasing livestock production, growing pet food safety concerns, and expanding focus on…
United States Sugar Decorations & Inclusions Market Surges on 5.80% CAGR - Custo …
According to DataM Intelligence, the global sugar decorations and inclusions market size was valued at US$2.15 billion in 2023 and is forecasted to reach US$3.45 billion by 2030, growing at a CAGR of 5.80% from 2023 to 2030. This steady growth is propelled by rising demand for personalized baked goods, expanding bakery and confectionery sectors, increasing consumer preference for visually appealing desserts, growth in organized retail for convenience foods, and…
Aluminum Extrusion Industry Forecast 2025-2031: Rising Demand in Automotive and …
Global Aluminum Extrusion Market reached US$ 78.7 billion in 2022 and is expected to reach US$ 117.8 billion by 2030, growing with a CAGR of 5.7% during the forecast period 2025-2031.
According to DataM Intelligence has published a new research report on "Aluminium Extrusion Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and…
United States Cellulose Gel Market Poised for 7.12% CAGR Through 2031 Driven by …
The global cellulose gel market is projected to reach at a CAGR of 7.12% from 2024 to 2031., according to DataM Intelligence.
United States: Recent Industry Developments
✅ In October 2025, Cargill Inc. launched a new line of clean-label food-grade cellulose gel derived from sustainable U.S. cotton sources, optimized for low-calorie bakery stabilizers amid rising demand for processed foods.
✅ In September 2025, DuPont de Nemours expanded its pharmaceutical-grade cellulose gel production in…
More Releases for DCT
DCT Antibody Market Growth and Trends: Regional Analysis and Key Players (2024-2 …
The DCT antibody market research report offers crucial insights into how the industry is evolving, highlighting key drivers of growth and the main revenue streams expected between 2024 and 2032. It's like a compass guiding business through the complexities of the market, presenting not only the current landscape but also the latest innovations shaping its future. This report becomes a strategic ally for companies, stakeholders, and industry players, offering a…
Digital Current Transformer (DCT) Market Analysis and Future Prospects for 2030
The world of the digital current transformer (dct) market is a complex and ever-evolving landscape, shaped by consumer demands and technological advancements. In this report, we delve into the depths of this market to provide a profound and comprehensive analysis, catering to a diverse audience that includes manufacturers, suppliers, distributors, and investors. Our primary goal is to empower industry stakeholders with invaluable insights to make informed decisions in a rapidly…
Global Automotive (DCT) Dual Clutch Transmission Market Research Report 2023-202 …
Global Automotive (DCT) Dual Clutch Transmission Market: Driven factors and Restrictions factors
The research report encompasses a comprehensive analysis of the factors that affect the growth of the market. It includes an evaluation of trends, restraints, and drivers that influence the market positively or negatively. The report also outlines the potential impact of different segments and applications on the market in the future. The information presented is based on historical milestones…
Unveiling the Power and Precision: Automotive Dual Clutch Transmission (DCT)
The dual clutch of transmission (DCT) has two manual transmissions, one transmission works for even-numbered gears, and other transmission works for odd-numbered gears. These two separate transmission systems helps avoid power loss and hence leads to better efficiency of the gearbox. Also, dual clutch transmission (DCT) offers a better fuel economy, as power flow in the powertrain i.e., from the engine to transmission is not interrupted. A six-speed dual clutch…
Dual Clutch Transmission (DCT) Market Size, Share, Growth | Report 2030
Acumen Research and Consulting has announced the addition of the "Dual Clutch Transmission (DCT) Market" report to their offering.
The Dual Clutch Transmission (DCT) Market Report 2030 is an in depth study analyzing the current state of the Dual Clutch Transmission (DCT) Market. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Dual Clutch Transmission (DCT) Market provides analysis…
Automotive DCT Market 2021 by Manufacturers, Regions, Type and Application, Fore …
The Automotive DCT Market report offers an in-depth assessment of market dynamics, the competitive landscape, segments, and regions in order to help readers to become familiar with the market. It particularly sheds light on market fluctuations, pricing structure, uncertainties, potential risks, and growth prospects to help players to plan effective strategies to gain success in the Automotive DCT market.  Importantly, it allows players to gain deep insights into the business…
